IL6 and hepatocellular carcinoma: In addition, pharmacological inhibition of APE1’s redox function prevents the activation of NK-kB, IL-6, and IL-8 induced by THF-α and free fatty acids in the human hepatocellular carcinoma cell line JHH-6 [53].